Comprehensive Financial Consultants Institutional’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
21,871
+372
| +2% | +$17.2K | 0.33% | 92 |
|
|
2025
Q1 | $1.31M | Sell |
21,499
-945
| -4% | -$57.6K | 0.47% | 78 |
|
|
2024
Q4 | $1.27M | Sell |
22,444
-96
| -0.4% | -$5.43K | 0.46% | 77 |
|
|
2024
Q3 | $1.17M | Buy |
22,540
+683
| +3% | +$35.3K | 0.43% | 83 |
|
|
2024
Q2 | $908K | Buy |
21,857
+3,655
| +20% | +$152K | 0.36% | 92 |
|
|
2024
Q1 | $987K | Buy |
18,202
+1,280
| +8% | +$69.4K | 0.41% | 84 |
|
|
2023
Q4 | $868K | Buy |
16,922
+2,402
| +17% | +$123K | 0.4% | 88 |
|
|
2023
Q3 | $843K | Sell |
14,520
-142
| -1% | -$8.24K | 0.44% | 82 |
|
|
2023
Q2 | $907K | Buy |
14,662
+401
| +3% | +$24.8K | 0.48% | 80 |
|
|
2023
Q1 | $988K | Buy |
14,261
+634
| +5% | +$43.9K | 0.56% | 68 |
|
|
2022
Q4 | $976K | Buy |
13,627
+82
| +0.6% | +$5.87K | 0.59% | 63 |
|
|
2022
Q3 | $966K | Buy |
13,545
+1,006
| +8% | +$71.7K | 0.64% | 55 |
|
|
2022
Q2 | $940K | Sell |
12,539
-78
| -0.6% | -$5.85K | 0.67% | 57 |
|
|
2022
Q1 | $967K | Sell |
12,617
-530
| -4% | -$40.6K | 0.67% | 53 |
|
|
2021
Q4 | $904K | Buy |
+13,147
| New | +$904K | 0.58% | 63 |
|